World News: 21:31 GMT Tuesday 7th May 2019. [Yahoo Business News Feed via SPi World News]
Mylan, one of the world’s biggest makers of generic drugs, has faced manufacturing problems, competition and declining prices that have created “unprecedented volatility,” Chief Executive Officer Heather Bresch said on a call with investors after reporting first-quarter results. “There is a tremendous amount of work being done” by the strategic committee, which will provide an update in the “near term,” Bresch said on a conference call after the company reported first-quarter earnings. Investors, however, were in no mood to wait, and Mylan shares fell 24 percent to $21.53.
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.